Component identification of modified sanmiao pills by UPLC-Xevo G2-XS QTOF and its anti-gouty arthritis mechanism based on network pharmacology and experimental verification-Reference-Cited by-同舟云学术

Component identification of modified sanmiao pills by UPLC-Xevo G2-XS QTOF and its anti-gouty arthritis mechanism based on network pharmacology and experimental verification

Published:2023-07 Issue: Volume:311 Page:116394
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Chen Ruyi,Li Fenfen,Zhou Kai,Xing Mengyu,Zhang Xiaoxi,Zhao Xinyu,Wu Chenxi,Han Ziwei,Zhou Yixuan,Yan Li,Xia Daozong

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference63 articles.

1. A new diepoxy-ent-kauranoid, rugosinin, from Isodon rugosus;Abbaskhan;Planta Med.,2003

2. Advances in our understanding of gout as an auto-inflammatory disease;Bodofsky;Semin. Arthritis Rheum.,2020

3. Innate immune pattern recognition: a cell biological perspective;Brubaker;Annu. Rev. Immunol.,2015

4. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the national health and nutrition examination survey, 2007-2016;Chen-Xu;Arthritis Rheumatol.,2019

5. Clinical observation of modified Sanmiao pills in the treatment of gouty arthritis;Chen;J. Emerg. Tradit. Chin. Med.,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Polydatin alleviates hyperuricemia combined with gouty arthritis in mice via regulating urate transporters, NLRP3 inflammasome and NF-κB pathway;Journal of Functional Foods;2023-06